Prognostic factors in gallbladder cancer: a comprehensive systematic review and meta-analysis
Hepatobiliary Surgery and Nutrition · 2025-06 · 14 (3) · 374-397
DOI: 10.21037/hbsn-23-502 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Hepatobiliary Surgery and Nutrition, 2025-06. Verfasst von Xiaoqian Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Gallbladder cancer (GBC) is one of the most common biliary cancers and is characterized by its high malignancy. Moreover, the incidence of GBC has been increasing over the decades, partly due to advancements in diagnostic techniques and devices. The purpose of this systematic review is to provide a comprehensive assessment of factors influencing the prognosis of GBC. We aim to identify and evaluate both established and controversial prognostic factors, including lymphocyte-monocyte ratio (LMR), adjuvant therapy, carbohydrate antigen 19-9 (CA199), carcinoembryonic antigen (CEA), tumor mutation status, surgical margins, the presence of gallstones, and jaundice.
Methods
We conducted a systematic search of eligible studies in PubMed, Cochrane Library, and Embase. Our analysis focused on data from GBC patients who had undergone surgical resection, with the primary outcome being overall survival. Forest plots were generated using hazard ratios (HRs) to visualize the effect sizes, and the Quality in Prognostic Factor Studies (QUIPS) tool was employed to assess the risk of bias.
Results
This study synthesized data from 52 studies, encompassing a total of 23,174 patients over the period of 2000 to 2022. Notably, several factors significantly influenced the outcomes of GBC, including LMR (HR =2.17), CEA (HR =1.81), CA199 (HR =1.56), lymph node stage (HR =2.03), T stage (HR =2.37), presence of invasion (HR =1.74), tumor location (HR =1.42), and surgical margins (HR =2.66). Additionally, chemotherapy (HR =0.75) and radiotherapy (HR =0.56) demonstrated marked improvements in overall survival compared to control arms. Jaundice and the presence of gallstones were not defined as independent predictors, as they reflect advanced stage symptoms in GBC.
Conclusions
The findings from this comprehensive review offer valuable insights into the assessment of the necessity for aggressive treatment approaches and the prognostication of GBC patients. Furthermore, there is a need for well-designed, ongoing studies to further advance our understanding of this challenging malignancy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
- Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, China.
Zitieren
APA
Hu, X., Zeng, D., Wen, N., Wang, Y., Lu, J., & Li, B. (2025). Prognostic factors in gallbladder cancer: a comprehensive systematic review and meta-analysis. Hepatobiliary Surgery and Nutrition, 14(3), 374-397. https://doi.org/10.21037/hbsn-23-502
Vancouver
Hu X, Zeng D, Wen N, Wang Y, Lu J, Li B. Prognostic factors in gallbladder cancer: a comprehensive systematic review and meta-analysis. Hepatobiliary Surgery and Nutrition. 2025;14(3):374-397. doi:10.21037/hbsn-23-502
BibTeX
@article{Hu2025,
author = {Hu, Xiaoqian and Zeng, Di and Wen, Ningyuan and Wang, Yaoqun and Lu, Jiong and Li, Bei},
title = {Prognostic factors in gallbladder cancer: a comprehensive systematic review and meta-analysis},
journal = {Hepatobiliary Surgery and Nutrition},
year = {2025},
volume = {14},
number = {3},
pages = {374--397},
doi = {10.21037/hbsn-23-502}
}
EUVIMED